Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes.

Tsai HC, Lu HY, Tsai CY, Liao HT, Chen MH, Tsai IL, Wu LL, Yang YY

Open source

DOI
10.1093/rheumatology/keag133
Published
2026 Apr 6
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag133,
  title = {Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes.},
  author = {Tsai HC and Lu HY and Tsai CY and Liao HT and Chen MH and Tsai IL and Wu LL and Yang YY},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag133},
  url = {https://doi.org/10.1093/rheumatology/keag133}
}

RIS

TY  - JOUR
TI  - Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes.
AU  - Tsai HC
AU  - Lu HY
AU  - Tsai CY
AU  - Liao HT
AU  - Chen MH
AU  - Tsai IL
AU  - Wu LL
AU  - Yang YY
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag133
UR  - https://doi.org/10.1093/rheumatology/keag133
ER  - 

APA

HC, T., HY, L., CY, T., HT, L., MH, C., IL, T., LL, W., & YY, Y. (2026). Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag133

Source records